Doreen Schmidl1, Katarzyna Jadwiga Witkowska2, Semira Kaya3, Carina Baar2, Henrik Faatz2, Johannes Nepp4, Angelika Unterhuber5, René Marcel Werkmeister5, Gerhard Garhofer2, Leopold Schmetterer1. 1. Department of Clinical Pharmacology, Medical University of Vienna, Austria Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Austria. 2. Department of Clinical Pharmacology, Medical University of Vienna, Austria. 3. Department of Ophthalmology, Paracelsus Medical University, Salzburg, Austria. 4. Department of Ophthalmology and Optometry, Medical University of Vienna, Austria. 5. Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Austria.
Abstract
PURPOSE: The aim of the present study was to evaluate the association between symptoms and different clinical signs in patients with dry-eye syndrome (DES). METHODS: Fifty-two patients with DES were included in the present cross-sectional study. For assessment of symptoms, the Ocular Surface Disease Index (OSDI) was used. Clinical parameters included measurement of tear break up time (BUT), corneal fluorescein staining, tear osmolarity, and ocular scattering index (OSI). Tear film thickness (TFT) was assessed using a custom-built optical coherence tomography (OCT) system with an axial resolution of 1.2 μm. In addition, impression cytology was performed. Correlation coefficients were calculated using linear regression analysis. RESULTS: The mean OSDI in the present study population was 28.9 ± 17.6, the mean TFT was 4.1 ± 1.3 μm. A significant negative correlation was found between OSDI and TFT (r = -0.34, P = 0.01). Tear film thickness correlated positively with BUT (r = 0.35, P = 0.01), but with no other signs of DES. No association was found between OSDI and the other evaluated signs. CONCLUSIONS: The study population mainly comprised of patients with mild to moderate DES. Tear film thickness as measured with a custom-built OCT device correlated with subjective symptoms in these patients. In agreement with previous data, the association between other signs and symptoms was weak in the present study. Measurement of TFT with OCT may become a valuable tool in the management of DES patients. (ClinicalTrials.gov number, NCT01753687.) Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: The aim of the present study was to evaluate the association between symptoms and different clinical signs in patients with dry-eye syndrome (DES). METHODS: Fifty-two patients with DES were included in the present cross-sectional study. For assessment of symptoms, the Ocular Surface Disease Index (OSDI) was used. Clinical parameters included measurement of tear break up time (BUT), corneal fluorescein staining, tear osmolarity, and ocular scattering index (OSI). Tear film thickness (TFT) was assessed using a custom-built optical coherence tomography (OCT) system with an axial resolution of 1.2 μm. In addition, impression cytology was performed. Correlation coefficients were calculated using linear regression analysis. RESULTS: The mean OSDI in the present study population was 28.9 ± 17.6, the mean TFT was 4.1 ± 1.3 μm. A significant negative correlation was found between OSDI and TFT (r = -0.34, P = 0.01). Tear film thickness correlated positively with BUT (r = 0.35, P = 0.01), but with no other signs of DES. No association was found between OSDI and the other evaluated signs. CONCLUSIONS: The study population mainly comprised of patients with mild to moderate DES. Tear film thickness as measured with a custom-built OCT device correlated with subjective symptoms in these patients. In agreement with previous data, the association between other signs and symptoms was weak in the present study. Measurement of TFT with OCT may become a valuable tool in the management of DES patients. (ClinicalTrials.gov number, NCT01753687.) Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Alina Messner; Corinna Fischak; Martin Pfister; Kornelia Schützenberger; Fabian Garreis; Friedrich Paulsen; Hannes Stegmann; Valentin Aranha Dos Santos; Gerhard Garhöfer; Leopold Schmetterer; René M Werkmeister Journal: Biomed Opt Express Date: 2019-08-28 Impact factor: 3.732
Authors: Laura Adelaide Deinema; Algis Jonas Vingrys; Holly Rose Chinnery; Laura Elizabeth Downie Journal: Transl Vis Sci Technol Date: 2017-05-22 Impact factor: 3.283
Authors: Corinna Fischak; Robert Klaus; René M Werkmeister; Christine Hohenadl; Martin Prinz; Leopold Schmetterer; Gerhard Garhöfer Journal: J Ophthalmol Date: 2017-06-12 Impact factor: 1.909
Authors: Ida G Fostad; Jon R Eidet; Tor P Utheim; Sten Ræder; Neil S Lagali; Edvard B Messelt; Darlene A Dartt Journal: PLoS One Date: 2016-05-05 Impact factor: 3.240
Authors: Karl G Stonecipher; Gail L Torkildsen; George W Ousler; Scot Morris; Linda Villanueva; David A Hollander Journal: Clin Ophthalmol Date: 2016-05-13